NSN 6505-01-208-5995 of Labetalol Hydrochlo - Parts Details
| Alternative NSN: 6505012085995 |
| Item Name: Labetalol Hydrochlo |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 012085995 |
| NCB Code: USA (01) |
| Manufacturers: Mutual Pharmaceutical Company Inc , Watson Labs Inc , Sandoz Inc , Eon Labs Llc , Glaxowellcome , Zenith Laboratories Inc , Schering Laboratories Institutional |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC53489-0355-05, NDC52544-0606-05, NDC00591-0606-05, NDC00185-0117-05, NDC00173-0347-44 under NSN 6505-01-208-5995 of Labetalol Hydrochlo manufactured by Mutual Pharmaceutical Company Inc, Watson Labs Inc, Sandoz Inc, Eon Labs Llc, Glaxowellcome.
Federal Supply Class of NSN 6505-01-208-5995 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-208-5995, 6505012085995
-
Part No Manufacturer Item Name QTY RFQ NDC53489-0355-05 Mutual Pharmaceutical Company Inc labetalol hydrochlo Avl RFQ NDC52544-0606-05 Watson Labs Inc labetalol hydrochlo Avl RFQ NDC00591-0606-05 Watson Labs Inc labetalol hydrochlo Avl RFQ NDC00185-0117-05 Sandoz Inc labetalol hydrochlo Avl RFQ NDC00185-0117-05 Eon Labs Llc labetalol hydrochlo Avl RFQ NDC00173-0347-44 Glaxowellcome labetalol hydrochlo Avl RFQ NDC00172-4365-70 Zenith Laboratories Inc labetalol hydrochlo Avl RFQ NDC00085-0752-05 Schering Laboratories Institutional labetalol hydrochlo Avl RFQ
Characteristics Data of NSN 6505012085995MRC Criteria Characteristic AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 200.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT CQCT PRIMARY CONTAINER TYPE BOTTLE CRLK PRIMARY CONTAINER CONTENT QUANTITY 500.000 TABLETS CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY LABETALOL HCL TABLETS 200MG 500S MDES MEDICAL DESIGNATION UNITED STATES PHARMACOPEIA
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | LABETALOL HCL TABLETS 200MG 500S |
| MDES | MEDICAL DESIGNATION | UNITED STATES PHARMACOPEIA |